Skip to content
The Policy VaultThe Policy Vault

lidocaine 5% patches — Medical Mutual

Postherpetic Neuralgia (PHN)

Initial criteria

  • Diagnosis of postherpetic neuralgia (PHN)

Reauthorization criteria

  • Response to therapy required for continuation

Approval duration

2 years